Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03756714 · ClinicalTrials.gov registry record

Safety and Performance of the TFCC FastFix in the Wrist

A clinical trial, sponsored by Smith & Nephew.

Completed
Registry status
88
Enrollment target

NCT03756714: Completed study, sponsored by Smith & Nephew.

NCT03756714 is a clinical trial that has completed, run by Smith & Nephew. The registered enrollment target is 88 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03756714 has completed, sponsored by Smith & Nephew.

COMPLETED
Registry status
88 participants
Enrollment target

Study Summary

Assess safety and performance post-market of the TFCC FastFix in the wrist.

Trial Details

FieldValue
Enrollment Target 88 participants
Start Date 2018-09-28
Est. Completion 2021-09-29
Smith & Nephew

72 total trials

What the finished NCT03756714 record still lists

NCT03756714 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 88 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT03756714 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03756714 about?

NCT03756714 is a clinical study titled "Safety and Performance of the TFCC FastFix in the Wrist". Assess safety and performance post-market of the TFCC FastFix in the wrist.

What is the current status of trial NCT03756714?

This trial is currently completed. The enrollment target is 88 participants. The study started on 2018-09-28. Estimated completion is 2021-09-29.

Who is sponsoring clinical trial NCT03756714?

This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03843463 · 88 participants · Phase 2

    Escitalopram and Language Intervention for Subacute Aphasia

  • NCT04066348 · 88 participants · Phase 2

    TNF-α Treatment of Blast-Induced Tinnitus

  • NCT04331704 · 88 participants · Phase 4

    ANCHORS Alcohol & Sexual Health Study: UH3 Project

  • NCT04536103 · 88 participants

    Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03756714, the US trial registry maintained by the National Library of Medicine. NCT03756714 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.